Patient recruitment and retainment are two of the biggest challenges in clinical research. While there is more than one approach to achieve patient enrollment and engagement, one solution is increasing access to data. Having access to a vast patient population offers the opportunity to provide study designers the ability to transform clinical trials and create truly patient-centric protocols.
Register for this webinar to explore how increased data access can help fill trials and retain patients by creating a patient-centric focus that keeps your study filled and running.
Faith Holmes, M.D., Medical Director, Vice President of Medical Affairs, Elligo Health Research
Faith Holmes, M.D., brings more than 30 years of experience in direct patient care, and 11 years of medical practice management to her role as Elligo’s medical director and vice president of medical affairs. Her unique perspective plays an important part in building the company’s network of research-ready physician practices and preparing them to conduct research. Holmes’ rich perspective — including experience in family medicine, hospice and palliative medicine that spans solo practice and single specialty and multispecialty group practices — allows her to build rapport with study managers, site staff, and investigators, and provide medical and scientific knowledge to support future growth.
Holmes is a Fellow of the American Academy of Family Physicians, a member of the American Medical Association, Texas Academy of Family Physicians, Texas Medical Association, and Travis County Medical Society. She earned her Bachelor of Science degree in chemistry and biology from Trevecca University, her Doctor of Medicine degree from Oral Roberts University School of Medicine and has been board certified in family medicine, hospice and palliative medicine, and as a hospice medical director.Message Presenter
Michael Ibara, Pharm.D., Chief Data Officer, Elligo Health Research
Michael Ibara has more than 20 years of experience in clinical research and development. Throughout his career, Ibara has sought to improve healthcare by bringing together healthcare data and digital technologies. His interests include regulatory and policy implications for digital healthcare, exploring the factors needed to allow interoperability of healthcare data for all stakeholders involved, and implications for the use of big data, machine learning and natural language processing to improve our ability to perform regulated clinical research.
Before joining Elligo, Ibara was the head of digital healthcare for the Clinical Data Interchange Standards Consortium (CDISC). There, he led the FDA eSource project and Healthcare Link efforts with registries, clinical trials and mobile health to enable use of real-world data from healthcare for regulated research and decision making. Prior to CDISC, Ibara was head of business development coordination and innovation and also head of pharmacovigilance innovation at Pfizer, where he worked for 15 years in various positions, leading implementations of global systems and large-scale technologies.Message Presenter
Who Should Attend?
The webinar will be of interest to members of the following industries:
- Medical Device
What You Will Learn
During this webinar, participants will explore:
- How access to a vast patient pool increases opportunities for real-world-compatible trial design
- The role of data in empowering a more diverse patient population
- Why an increased range of potential trial participants allows researchers to engage physicians, establishing an authentic interaction between patients, researchers and physicians
- How data access combined with patient-centric trials leads to streamlined inclusion/exclusion and expedited timelines
Elligo Health Research
Elligo Health Research®, a healthcare-enabling research organization, uses electronic health records and the trusted patient and physician relationship to ensure all patients have access to clinical research as a care option. Powered by our Goes Direct® approach and novel IntElligo® Research Stack clinical technology, our team provides access to the best healthcare experts, patients, and research technologies. We engage physicians and patients who otherwise would not participate in clinical research and accelerate the development of new pharmaceutical, biotechnology, and medical device and diagnostic products.